The right isn't covering this

6 outlets · Left 3 · Center 3 · Right 0
No right-side outlet ran this
Each wing's outermost outlet, headline quoted verbatim - framing shows clearest at the edges. Center outlets appear with every other headline below.
Supreme Court kick-starts Trump's mass deportation machine
10 right outlets ran this →ICE arrests illegal alien accused of sexually assaulting children after Fairfax County release: DHS
10 right outlets ran this →Senate Democrats Block Ratepayer Protection Act Aimed at Shielding Families From Data Center Costs
9 right outlets ran this →The right's own top stories from this same window, ranked by how many of its outlets ran each one. Every headline is that side's own wording, quoted verbatim, and links to the story's full coverage here.
each line: one outlet's first article — above the track left · below right · across center
First reported by Time (Lean left); 6 outlets over 16h.
Time · +2 min NBC News · +15 min Reuters · +13h Semafor · +16h CBS News · +16h CNBC
Retatrutide is the latest experimental weight-loss drug with promising clinical trial results, but it's not yet approved by the FDA. Dr. Céline Gounder has the latest.
Read at cbsnews.com →Regeneron weight-loss drug halves muscle loss in combination with Novo's semaglutide in trial Reuters
Read at reuters.com →Lilly said it plans to start Phase 3 trials on the combo regimen adding its amylin drug eloralintide to tirzepatide at the end of the year.
Read at cnbc.com →Novo’s agreement with Hengrui Pharma, which struck an even bigger deal with GSK last year, highlights the rapid advances in China’s cutting-edge biotech sector.
Read at semafor.com →Each blurb is the outlet's own feed summary, quoted unedited. Nothing here is generated.
8 articles, newest first · filter by side
Every headline that clustered into this story, newest first. Links go straight to the publisher - no article text is stored here, and the one image is an unmodified copy of the publisher's own thumbnail.